Share Twitter LinkedIn Facebook Email Dr. David Adelstein, MD of Cleveland Clinic discusses novel agents under investigation that might find a future role in adjuvant therapy for oral cavity and other head & neck carcinomas at the ASTRO Head and Neck Symposium 2016.
ASH 2025 MDS/ALL Highlights: Verona Trial Lessons & CLEVER Pathway | Dr. Jeyakumar Acute Lymphoblastic Leukemia 5 Mins Read
Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani Acute Lymphoblastic Leukemia 3 Mins Read